Results 101 to 110 of about 1,423 (137)

D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome. [PDF]

Int J Mol Sci, 2020
Pericuesta E, Laguna-Barraza R, Ramos-Ibeas P, Gutierrez-Arroyo JL, Navarro JA, Vera K, Sanjuan C, Baixeras E, de Fonseca FR, Gutierrez-Adan A.   +9 more
europepmc   +1 more source

PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol

Frontiers in Endocrinology, 2021
Giovanni Monastra, Ivana Vucenik, Abdel Halim Harrath, Saleh H. Alwasel, Zdravko A. Kamenov, Antonio Simone Laganà, Noemi Monti, Valeria Fedeli, Mariano Bizzarri   +8 more
doaj   +1 more source

Treatment With a Patented 3.6:1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted Reproductive Technique (ART) Failures: A Series of Case Reports. [PDF]

Clin Med Insights Case Rep
Armijo-Sánchez A, Benítez Castillo N, García-Vidal E, Luna Chadid M, Salvador Ballada C, Valls Ricart G, Torres Pellens V.   +6 more
europepmc   +1 more source

Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study. [PDF]

J Ovarian Res, 2019
Troisi J, Cinque C, Giugliano L, Symes S, Richards S, Adair D, Cavallo P, Sarno L, Scala G, Caiazza M, Guida M.   +10 more
europepmc   +1 more source

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. [PDF]

Cochrane Database Syst Rev, 2017
Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH.   +4 more
europepmc   +1 more source

D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress. [PDF]

Acta Pharmacol Sin, 2018
Zhao SS, Li NR, Zhao WL, Liu H, Ge MX, Zhang YX, Zhao LY, You XF, He HW, Shao RG.   +9 more
europepmc   +1 more source

The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.

Gynecol Obstet Invest
Pustotina O, Myers SH, Unfer V, Rasulova I.   +3 more
europepmc   +1 more source

d-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).

Gynecol Obstet Invest
Dinicola S, Unfer V, Soulage CO, Yap-Garcia MIM, Bevilacqua A, Benvenga S, Barbaro D, Wdowiak A, Nordio M, Dewailly D, Appetecchia M, Aragona C, Espinola MSB, Bizzarri M, Cavalli P, Colao A, D'Anna R, Vazquez-Levin MH, Hernàndez Marin I, Kamenov Z, Laganà AS, Monastra G, Montanino Oliva M, Cenk Özay A, Pintaudi B, Porcaro G, Pustotina O, Pkhaladze L, Prapas N, Roseff S, Salehpour S, Stringaro A, Tugushev M, Unfer V, Vucenik I, Facchinetti F.   +35 more
europepmc   +1 more source

A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women. [PDF]

Int J Endocrinol, 2016
Benelli E, Del Ghianda S, Di Cosmo C, Tonacchera M, Tonacchera M.   +4 more
europepmc   +1 more source

Impact of Immune Cells on IgA Vasculitis via Metabolites and Inflammatory Cytokines. [PDF]

J Clin Immunol
Xie M, Zhou N, Liang Q, Lin Z, Yao Y.
europepmc   +1 more source